Table 1.
Baseline characteristics of the patients
| INDI-FREEZE | Control | P-value | |
|---|---|---|---|
| Patients, n | 50 | 50 | |
| Age (years) | 67 ± 12 | 68 ± 10 | 0.974 |
| Body mass index | 26.6 ± 4 | 27.7 ± 5 | 0.531 |
| CHA2DS2-VASc score | 2.6 ± 1.7 | 2.6 ± 1.6 | 0.999 |
| LA volume index (mL/m²) | 33.0 ± 8.8 | 33.2 ± 9.3 | 0.932 |
| Female gender, n (%) | 25 (50) | 23 (44) | 0.689 |
| Paroxysmal AF, n (%) | 50 (100) | 50 (100) | 0.999 |
| Congestive heart failure, n (%) | 2 (4) | 2 (4) | 0.999 |
| Arterial hypertension, n (%) | 32 (64) | 34 (68) | 0.673 |
| Diabetes mellitus type 2, n (%) | 1 (2) | 5 (10) | 0.921 |
| Coronary artery disease, n (%) | 12 (24) | 7 (14) | 0.892 |
| Prior stroke/TIA, n (%) | 5 (10) | 3 (6) | 0.461 |
Values are counts (n), n (%), or mean ± standard deviation.
AF, atrial fibrillation; LA, left atrium.